Testing effectiveness (Phase 2)Active Not RecruitingNCT04223024
What this trial is testing
Concurrent Chemoradiotherapy With Nimotuzumab for High Risk Nasopharyngeal Carcinoma
Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 246